Compare BIO & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | CAE |
|---|---|---|
| Founded | 1952 | 1947 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.2B |
| IPO Year | 1994 | 2002 |
| Metric | BIO | CAE |
|---|---|---|
| Price | $386.11 | $24.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $339.75 | $33.33 |
| AVG Volume (30 Days) | 236.0K | ★ 668.4K |
| Earning Date | 04-30-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,583,200,000.00 | N/A |
| Revenue This Year | $2.74 | $4.97 |
| Revenue Next Year | $3.20 | N/A |
| P/E Ratio | ★ N/A | $35.13 |
| Revenue Growth | ★ 0.65 | N/A |
| 52 Week Low | $236.73 | $22.76 |
| 52 Week High | $396.23 | $34.24 |
| Indicator | BIO | CAE |
|---|---|---|
| Relative Strength Index (RSI) | 69.94 | 41.69 |
| Support Level | $287.41 | $22.76 |
| Resistance Level | $396.23 | $26.41 |
| Average True Range (ATR) | 11.10 | 0.66 |
| MACD | -0.93 | -0.21 |
| Stochastic Oscillator | 79.56 | 25.19 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: i) Civil Aviation: Provides comprehensive training solutions for flight, cabin, maintenance, ground personnel and air traffic controllers in commercial, business and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training and crew sourcing services, as well as airline operations digital solutions; and ii) Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.